Immunovant Inc.
IMVT | NASDAQ
$37.18
+$0.23 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$37.16
-$0.02 (-0.05%)
Pre-market:
Sep 22, 2026, 8:31 AM ET
Market Data
Market Cap $7.67B
Enterprise Value $6.88B
Beta 0.81
Average Volume 1.57M
Shares Outstanding (Diluted) 205.55M
Shares Change YoY 20.29%
Institutional Ownership 60.63%
Exchange NASDAQ
ISIN US45258J1025
Price Performance
Price Change 1M -15.5%
Price Change 3M -1.2%
Price Change 6M 50.2%
Price Change YTD 43.5%
Price Change 1Y 138.5%
Price Change 3Y 82.3%
Price Change 5Y 329.8%
1M CAGR (ann.) -6.9%
1Y CAGR (ann.) 141.4%
5Y CAGR (ann.) 33.7%
All-Time CAGR 19.9%
Valuation
PE Ratio -13.18
Forward PE N/A
PEG Ratio -20.38
Forward PEG 22.85
PS Ratio 1,081.61
Forward PS 1,155.00
PB Ratio 10.44
P/FCF Ratio -18.52
P/Adj. FCF Ratio -16.49
P/OCF Ratio -18.41
EV/Sales 969.17
EV/EBIT -12.76
EV/EBITDA -12.77
EV/FCF -16.60
Earnings Yield -7.6%
FCF Yield -5.4%
Adj. FCF Yield -6.1%
Financial Health
Net Cash $797.8M
Total Debt $0
Cash & Short-Term Investments $797.8M
Total Assets $852.49M
Current Ratio 7.27
Quick Ratio 7.27
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 35.16
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 97.1%
Operating Profit Margin -7877.5%
EBITDA Margin -7590.1%
Net Profit Margin -7585.9%
FCF Margin -5839.5%
Adj. FCF Margin -6558.1%
SBC / Revenue 718.6%
SBC Impact (per share) -12.3%
Returns
Return on Assets -63.1%
Return on Equity -69.6%
Return on Invested Capital -75.9%
Return on Capital Employed -76.0%
Return on Tangible Assets -63.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -17.6%
EPS CAGR 5Y -16.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y -23.8%
FCF CAGR 5Y -27.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 23
EPS Growth Next 3Y 11.2%
Revenue Growth Next 3Y 284.5%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.73
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $7.1M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $40
Price Target Upside 7.6%
Cash Flow
Operating Cash Flow $-414.3M
Free Cash Flow $-414.31M
Adj. Free Cash Flow $-465.3M
FCF Per Share -$2.02
OCF Per Share -$2.02
OCF/S Ratio -5839.4%
Income Statement
Revenue $7.1M
Gross Profit $6.89M
Operating Income $-558.91M
EBITDA $-538.52M
Net Income $-538.22M
EPS (Diluted) -$2.82
Revenue / Employee $22.52K
Profit / Employee $-1.71M
Employees 315
Add to Watchlist
Select watchlists to add or remove IMVT